Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Antitumor monoclonal antibodies must bind to tumor antigens with high affinity to achieve durable tumor retention. This has spurred efforts to generate high affinity antibodies ...
Abstract The identification of tumor-specific cell surface antigens is a critical step toward the development of targeted therapeutics for cancer. The epitope space at the tumor...
h-index: Number of publications with at least h citations each.